Asthma News

Using oscillometry testing, physicians may identify patients with asthma and obesity who have a phenotype that may be related to worse symptoms and more severe disease, according to a study published in CHEST.

Incidence rates of asthma with recurrent exacerbations vary with time of surveillance, decade of birth, age, race, ethnicity and census region, according to a study published in The Journal of Allergy and Clinical Immunology.

A digital strategy for evidence-based asthma control led to modest improvements in medication adherence and significantly lower cost and treatment burdens, according to a study published in The Lancet Respiratory Medicine.

Patients with poor sleep patterns and higher genetic susceptibility have an additive higher risk for asthma, with lower risks among patients with healthy sleep patterns, according to a study published in BMJ Open Respiratory Research.

Fractional exhaled nitric oxide levels predicted treatment response to dupilumab among patients who had uncontrolled moderate to severe asthma, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Patients with asthma who slept less than 6 hours a night experienced poorer asthma control and greater risk for moderate to severe exacerbations, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Patients with asthma and specific eosinophil and IgE levels experienced greater improvements in exacerbations and FEV1 with dupilumab compared with other biologics, according to a study.

SAN ANTONIO — Multiple factors may predict whether pediatric patients will be admitted to the hospital for acute asthma exacerbations, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SAN ANTONIO — Patients with severe eosinophilic asthma experienced improvements in their symptoms within a week after taking benralizumab, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Following 6 months of dupilumab treatment, 57% of patients with NSAID-exacerbated respiratory disease had higher aspirin tolerance than before treatment, according to study results published in European Respiratory Journal.